Marshall Wace’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-333,161
| Closed | -$2.07M | – | 2457 |
|
|
2024
Q2 | $2.07M | Buy |
333,161
+107,588
| +48% | +$667K | ﹤0.01% | 1235 |
|
|
2024
Q1 | $2.13M | Sell |
225,573
-279,529
| -55% | -$2.64M | ﹤0.01% | 1167 |
|
|
2023
Q4 | $3.41M | Sell |
505,102
-543,544
| -52% | -$3.67M | 0.01% | 868 |
|
|
2023
Q3 | $4.66M | Buy |
1,048,646
+1,031,246
| +5,927% | +$4.58M | 0.01% | 797 |
|
|
2023
Q2 | $57.4K | Sell |
17,400
-103,600
| -86% | -$342K | ﹤0.01% | 1920 |
|
|
2023
Q1 | $345K | Buy |
121,000
+105,474
| +679% | +$301K | ﹤0.01% | 1773 |
|
|
2022
Q4 | $113K | Sell |
15,526
-4,589
| -23% | -$33.4K | ﹤0.01% | 2181 |
|
|
2022
Q3 | $162K | Buy |
+20,115
| New | +$162K | ﹤0.01% | 2374 |
|
|
2022
Q1 | – | Sell |
-13,513
| Closed | -$239K | – | 2838 |
|
|
2021
Q4 | $239K | Sell |
13,513
-138,176
| -91% | -$2.44M | ﹤0.01% | 2428 |
|
|
2021
Q3 | $4.28M | Buy |
+151,689
| New | +$4.28M | 0.02% | 876 |
|